You are here

Post Marketing Observational Study of Reformulated BeneFIX

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Chamberry, Cedex, 73011 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 +
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects with Hemophilia B already receiving or starting treatment with reformulated
BeneFIX.

- Subjects who have dated and signed the informed consent form.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Ongoing treatment of Hemophilia B by a product other than reformulated BeneFIX.

- Participation in the European prospective registry of patients with Hemophilia B
treated with BeneFIX (Wyeth protocol 3090A-101039).

NCT00835068
Pfizer
Completed
Post Marketing Observational Study of Reformulated BeneFIX

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now